Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Veeva SystemsVEEV -1.05%90 EV-to-OCF is 19.85 as of Aug. 22, 2026, which is 48% below its 10-year median of 38.48. GuruFocus rates VEEV with a GF Score™ of 90/100 and a GF Value™ of $292.48 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 682 Healthcare Providers & Services companies, Veeva Systems ranks worse than 78.89% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Veeva Systems's Enterprise Value is $33,060 Mil.
Veeva Systems's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 was $1,665 Mil. Therefore, Veeva Systems's EV-to-OCF for today is 19.85.
The historical rank and industry rank for Veeva Systems's EV-to-OCF or its related term are showing as below:
VEEV'
s EV-to-OCF Range Over the Past 10 Years
Min: 10.95 Med: 38.48 Max: 114.02
Current: 19.85
During the past 13 years, the highest EV-to-OCF of Veeva Systems was 114.02. The lowest was 10.95. And the median was 38.48.
VEEV's EV-to-OCF is ranked worse than 78.89% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.755
vs VEEV: 19.85
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Veeva Systems's PE Ratio (TTM) for today is calculated as:
Veeva Systems's share price for today is $247.90.
Veeva Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.610.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Veeva Systems EV-to-OCF Related Terms
Veeva Systems EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Veeva Systems's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Veeva Systems's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Veeva Systems's EV-to-OCF falls into.
Veeva Systems's current Enterprise Value is $33,060 Mil.
Veeva Systems's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,665 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (VEEV) has a EV-to-OCF of 19.85 as of Aug. 22, 2026. This is 48% below median its historical median of 38.48. Over the past decade, Veeva Systems' EV-to-OCF has ranged from 10.95 to 114.02. According to the industry distribution chart, Veeva Systems ranks #538 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 78.9%.
Is Veeva Systems' EV-to-OCF too high?
Veeva Systems' current EV-to-OCF of 19.85 is 48% below median its 10-year median of 38.48. Over the past 10 years, this metric has ranged from a low of 10.95 to a high of 114.02. The Healthcare Providers & Services industry median EV-to-OCF is 8.76. Veeva Systems' value of 19.85 is 126.7% above this industry median. Based on the distribution chart, Veeva Systems ranks #538 out of 682 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Veeva Systems has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' EV-to-OCF compare to BTSG and HQY?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #538 out of 682 companies for EV-to-OCF. This places Veeva Systems in the lower half of its industry. The industry median EV-to-OCF is 8.76. Veeva Systems' value of 19.85 is 126.7% above this benchmark. Historically, Veeva Systems' own EV-to-OCF has ranged from 10.95 to 114.02 over the past decade. While the company's 10-year median is 38.48 vs. the industry median of 8.76, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.76, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current EV-to-OCF of 19.85 is 126.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current EV-to-OCF is 19.85, which is 48% below median its own 10-year median of 38.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Modestly Undervalued. The stock's GF Value™ is $292.48, compared to a current price of $247.90 — trading 15.2% below its estimated fair value. The current EV-to-OCF is 19.85, which is 48% below median its 10-year median of 38.48 and 126.7% above the Healthcare Providers & Services industry median of 8.76. Veeva Systems' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Veeva Systems (VEEV), the current EV-to-OCF is 19.85 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $247.90 is trading 15.2% below its estimated GF Value™ of $292.48.
GuruFocus considers Veeva Systems to be Modestly Undervalued.
Key valuation signals for VEEV:
EV-to-OCF: 19.85 (48% below median its 10-year median of 38.48)
GF Value™: $292.48 vs. price of $247.90 (15.2% below fair value)
Industry Position: 126.7% above the Healthcare Providers & Services median (#538 of 682)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
90GF Score
Get the complete analysis for VEEV
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
